SI2035385T1 - Inhibitorji akt proteinske kinaze b - Google Patents

Inhibitorji akt proteinske kinaze b

Info

Publication number
SI2035385T1
SI2035385T1 SI200730212T SI200730212T SI2035385T1 SI 2035385 T1 SI2035385 T1 SI 2035385T1 SI 200730212 T SI200730212 T SI 200730212T SI 200730212 T SI200730212 T SI 200730212T SI 2035385 T1 SI2035385 T1 SI 2035385T1
Authority
SI
Slovenia
Prior art keywords
akt
inhibitors
protein kinase
kinase
protein
Prior art date
Application number
SI200730212T
Other languages
English (en)
Inventor
Sajan Joseph
Renhua Li
Michael Ray Myers
Aktham Aburub
Jenny Pingqi Dai
Christopher Randall Schmid
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SI2035385T1 publication Critical patent/SI2035385T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SI200730212T 2006-06-20 2007-06-12 Inhibitorji akt proteinske kinaze b SI2035385T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80526006P 2006-06-20 2006-06-20
US88576507P 2007-01-19 2007-01-19
EP07798410A EP2035385B1 (en) 2006-06-20 2007-06-12 Inhibitors of akt (protein kinase b)

Publications (1)

Publication Number Publication Date
SI2035385T1 true SI2035385T1 (sl) 2010-05-31

Family

ID=38834248

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200730212T SI2035385T1 (sl) 2006-06-20 2007-06-12 Inhibitorji akt proteinske kinaze b

Country Status (28)

Country Link
US (1) US7998977B2 (sl)
EP (1) EP2035385B1 (sl)
JP (1) JP2009541335A (sl)
KR (1) KR101067551B1 (sl)
AR (1) AR061240A1 (sl)
AT (1) ATE455102T1 (sl)
AU (1) AU2007261120A1 (sl)
BR (1) BRPI0713136A2 (sl)
CA (1) CA2652612A1 (sl)
CL (1) CL2007001752A1 (sl)
DE (1) DE602007004333D1 (sl)
DK (1) DK2035385T3 (sl)
DO (1) DOP2008000053A (sl)
EA (1) EA015712B1 (sl)
EC (1) ECSP088992A (sl)
ES (1) ES2336630T3 (sl)
HR (1) HRP20100147T1 (sl)
IL (1) IL195005A0 (sl)
MA (1) MA30757B1 (sl)
MX (1) MX2008015904A (sl)
NO (1) NO20090289L (sl)
PE (1) PE20080338A1 (sl)
PL (1) PL2035385T3 (sl)
PT (1) PT2035385E (sl)
SI (1) SI2035385T1 (sl)
TN (1) TNSN08529A1 (sl)
TW (1) TW200812970A (sl)
WO (1) WO2007149730A2 (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2300011A4 (en) 2008-05-27 2012-06-20 Dmi Life Sciences Inc METHODS AND THERAPEUTIC COMPOUNDS
JP2013537195A (ja) 2010-09-07 2013-09-30 ディエムアイ アクイジション コーポレイション 疾患の治療
CN103841934A (zh) 2011-10-10 2014-06-04 安皮奥制药股份有限公司 增强免疫耐受的可植入的医疗装置及其制造与植入方法
KR102032400B1 (ko) 2011-10-10 2019-10-15 앰피오 파마슈티컬스 인코퍼레이티드 퇴행성 관절 질환의 치료
EP2771007B1 (en) 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
WO2014145729A2 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
CN105764501A (zh) 2013-07-26 2016-07-13 现代化制药公司 改善比生群治疗效益的组合物
EP4066836A1 (en) 2014-08-18 2022-10-05 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
WO2016201605A1 (zh) * 2015-06-15 2016-12-22 廖勇 一种治疗乙型肝炎病毒的靶点
WO2016209969A1 (en) 2015-06-22 2016-12-29 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
US10722484B2 (en) 2016-03-09 2020-07-28 K-Gen, Inc. Methods of cancer treatment
JP7472391B2 (ja) 2020-07-22 2024-04-22 南京正大天晴制薬有限公司 ジヒドロピリド［２，３－ｄ］ピリミジノン誘導体の塩及び結晶形

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152807A0 (en) 2000-05-30 2003-06-24 Peptor Ltd Protein kinase inhibitors
MXPA05010440A (es) 2003-03-28 2005-11-04 Lilly Co Eli Amidas del acido isoquinolina-5-sulfonico como inhibidores de la akt (proteina quinasa b).
GB0317315D0 (en) 2003-07-24 2003-08-27 Astex Technology Ltd Pharmaceutical compounds
US7449477B2 (en) * 2003-11-25 2008-11-11 Eli Lilly And Company 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (protein kinase B)

Also Published As

Publication number Publication date
DOP2008000053A (es) 2009-01-15
DE602007004333D1 (de) 2010-03-04
MA30757B1 (fr) 2009-10-01
PT2035385E (pt) 2010-03-01
AR061240A1 (es) 2008-08-13
NO20090289L (no) 2009-01-19
DK2035385T3 (da) 2010-03-22
EP2035385B1 (en) 2010-01-13
EA200970041A1 (ru) 2009-06-30
AU2007261120A1 (en) 2007-12-27
PL2035385T3 (pl) 2010-06-30
WO2007149730A2 (en) 2007-12-27
MX2008015904A (es) 2009-01-12
BRPI0713136A2 (pt) 2012-04-17
ATE455102T1 (de) 2010-01-15
EA015712B1 (ru) 2011-10-31
KR101067551B1 (ko) 2011-09-27
IL195005A0 (en) 2009-08-03
TNSN08529A1 (en) 2010-04-14
WO2007149730A3 (en) 2008-04-24
EP2035385A2 (en) 2009-03-18
ES2336630T3 (es) 2010-04-14
US7998977B2 (en) 2011-08-16
US20090221633A1 (en) 2009-09-03
CL2007001752A1 (es) 2008-01-18
JP2009541335A (ja) 2009-11-26
PE20080338A1 (es) 2008-04-25
KR20090015978A (ko) 2009-02-12
TW200812970A (en) 2008-03-16
HRP20100147T1 (hr) 2010-04-30
CA2652612A1 (en) 2007-12-27
ECSP088992A (es) 2009-01-30

Similar Documents

Publication Publication Date Title
HUS2200052I1 (hu) Imidazotriazinok és imidazopirimidinek mint kinázgátlók
IL195005A0 (en) Inhibitors of akt (protein kinase b)
HUS1500049I1 (hu) Protein kináz inhibitor vegyületek és készítmények
HK1129298A1 (en) Dihydrodiazepines useful as inhibitors of protein kinases
HRP20141260T1 (en) Compounds and compositions as protein kinase inhibitors
EP2076128A4 (en) PROTEIN CHINESE INHIBITOR AND ITS USE METHOD
IL194699A0 (en) Tetrahydropteridines useful as inhibitors of protein kinases
IL198487A0 (en) 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
IL197724A0 (en) Compounds and compositions as protein kinase inhibitors
IL198315A0 (en) Compounds and compositions as protein kinase inhibitors
IL194845A0 (en) Inhibitors of c-fms kinase
IL198398A0 (en) 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
WO2008036459A8 (en) Inhibitors of rho kinase
ZA200806871B (en) Dihydrodiazepines useful as inhibitors of protein kinases
HK1208701A1 (en) Means for inhibiting the expression of protein kinase
GB0608823D0 (en) Inhibitors of P13 kinase
GB0608837D0 (en) Inhibitors of MAP kinase
IL194491A0 (en) Thiazolyldihydroindazole derivatives as protein kinase inhibitors
ZA201008026B (en) Inhibitors of ikk-b serine-threonine protein kinase
ZA200810573B (en) Substituted 3-cyanopyridines as protein kinase inhibitors
ZA200809545B (en) Inhibitors of Akt (protein kinase B)
IL197981A0 (en) Kinase inhibitors
GB0621720D0 (en) Inhibitors of ikk- serine-threonine protein kinase
GB0621719D0 (en) Ikk- serine-threonine protein kinase inhibitors
GB0621977D0 (en) Inhibitors of IGF-1R protein kinase